Background
Rhabdomyosarcomas are a rare but aggressive type of cancer in children and adolescents. There are approximately 350 new diagnoses of childhood RMS in the United States per year. The outcomes for high-risk patients with this disease have not significantly improved in the last several decades and survival of metastatic or relapsed disease remains extremely poor. In rhabdomyosarcoma the tumor cells resemble dividing muscle cells.
